N Al-Awwal, F Dweik, S Mahdi, M El-Dweik… - Pathogens, 2022 - mdpi.com
Development and deployment of biosensors for the rapid detection of the 2019 novel severe acute respiratory syndrome—coronavirus 2 (SARS-CoV-2) are of utmost importance and …
S Kang, W Peng, Y Zhu, S Lu, M Zhou, W Lin… - International journal of …, 2020 - Elsevier
Viral respiratory diseases such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) always pose a severe threat to people. First identified in …
Y Zhu, J Li, Z Pang - Asian Journal of Pharmaceutical Sciences, 2021 - Elsevier
SARS-CoV-2 has been marked as a highly pathogenic coronavirus of COVID-19 disease into the human population, causing over 5.5 million confirmed cases worldwide. As COVID …
N Zhang, C Li, Y Hu, K Li, J Liang, L Wang, L Du… - Microbes and …, 2020 - Elsevier
A novel coronavirus, designated as SARS-CoV-2, first emerged in Wuhan City, Hubei Province, China, in late December 2019. The rapidly increasing number of cases has …
As of 27 December 2021, SARS-CoV-2 has infected over 278 million persons and caused 5.3 million deaths. Since the outbreak of COVID-19, different methods, from medical to …
SY Wu, HS Yau, MY Yu, HF Tsang… - Expert review of …, 2020 - Taylor & Francis
Introduction The emergence of anovel coronavirus identified in patients with unknown cause of acute respiratory disease in Wuhan, China at the end of 2019 has caused aglobal …
The world is facing lockdown for the first time in decades due to the novel coronavirus COVID-19 (SARS-CoV-2) pandemic. This has led to massive global economic disruption …
The recent epidemic outbreak of a novel human coronavirus called SARS-CoV-2 and causing the respiratory tract disease COVID-19 has reached worldwide resonance and a …
The emergence of coronavirus disease 2019 (COVID-19) in December 2019 has resulted in over 20 million cases and 741,808 deaths globally, affecting more than 200 countries …